Clinical Trials Logo

Filter by:
NCT ID: NCT05654597 Recruiting - Lung Diseases Clinical Trials

French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease

Start date: April 1, 2023
Phase:
Study type: Observational

The objective of this multicentre prospective study is to validate CAPTURE as a French case finding tool for undiagnosed patients suffering from obstructive pulmonary disease.

NCT ID: NCT05659550 Recruiting - Heart Failure Clinical Trials

Move With Air: Physiological Response Assessment

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

A fan blowing cool air to the face has been shown to alleviate breathlessness in malignant and non-malignant disease at rest and during exercise, however the underlying physiological mechanisms remain unknown. This random order, three-condition design study will explore physiological mechanisms of breathlessness relief with fan-to-face therapy during constant-rate exercise in people with cardiorespiratory disease.

NCT ID: NCT05660226 Recruiting - Hypertension Clinical Trials

Telemonitoring and E-Coaching in Hypertension

TECH
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Rationale: Hypertension is the most significant risk factor for cardiovascular disease and can be mitigated by lifestyle and medical management. Telemonitoring as a novel management approach to perform hypertension management at distance has been thriving but became indispensable during the COVID-19 pandemic. However, evidence of an effective implementation for telemonitoring remains to be elucidated. Hypothesis: Telemonitoring with a smartphone application, which includes mixed automated services for a personal counselling program (PCP), on top of self-monitoring (SM) will lead to improvement of hypertension control rates, medication adherence and lifestyle behaviors and lower health care costs in patients with hypertension when compared to usual care. Objective: To investigate the effects of PCP+SM on hypertension control rate and lifestyle behaviors as compared with usual care. Study design: The study is a non-blinded randomized controlled clinical trial in adults with hypertension, in a multicenter hospital setting . We will randomize participants in a 1:1 fashion to the intervention group (PCP+SM), or to the control group (usual care). Study population: 400 patients, patients, aged ≥18 years with hypertension (RR >140/90) Main study outcome: hypertension control rate (%<140/90mmHg) after 6 months (as measured by the SPRINT protocol)

NCT ID: NCT05660616 Recruiting - Clinical trials for Malignant Pleural Mesothelioma

Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma

Start date: April 1, 2023
Phase: Phase 2
Study type: Interventional

Mesothelioma is an aggressive form of cancer. Treatments are available, but for many people, a cure isn't possible. This thesis is to assess the efficacy and safety of switch-maintenance Gemcitabine in Mesothelioma patients after first line chemotherapy (Pemetrexed-Platinum)

NCT ID: NCT05666167 Recruiting - Arthritis Clinical Trials

Expanding Exercise Programming for Veterans Through Telehealth

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the acceptability and feasibility of a group telehealth exercise program for Veterans with lower extremity osteoarthritis (OA). Methods: This is a randomized pilot trial where Veterans (n=50) receive a group telehealth exercise program (3 months), followed by an exercise maintenance phase (6 months) that includes either text messaging alone or text messaging plus group telehealth exercise booster sessions. The primary outcomes for this study are feasibility and acceptability of the intervention. Feasibility will be assessed through number and source of referrals, recruitment, and retention. Acceptability will be assessed through surveys and interviews for participants and providers addressing reasons for participation, satisfaction, perceived appropriateness, and overall experience containing Likert scales and both yes/no and open-ended questions. Exploratory outcomes, assessed at multiple time points during the course of the study, will measure changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and changes in performance measure and physical activity assessed remotely through individual telehealth sessions. Data will be collected at baseline, 3-, 6-, and 9-month follow-up.

NCT ID: NCT05668039 Recruiting - Clinical trials for Post-Acute COVID-19 Syndrome

Enhanced External Counterpulsation to Treat Long COVID-19 Fatigue

EXPECT
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The goal of this double blind, outcome-assessor blind, randomized controlled trial, is to compare the effectiveness of external encounter counterpulsation (EECP) versus sham procedure in participants with long COVID-19 fatigue. The main question[s] it aims to answer are: - Whether EECP improves fatigue score - Whether EECP improves quality of life, six-minute walk test, and endothelial function Participants will attend 15 sessions (1-hour each) of EECP during 5 weeks Researchers will compare EECP versus sham procedure for the above outcomes.

NCT ID: NCT05673005 Recruiting - Clinical trials for Erectile Dysfunction Following Radical Prostatectomy

MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The investigators are doing this research to evaluate the efficacy and safety of topical MED3000 therapy in men with persistent erectile dysfunction 1.5 to 4 years following radical prostatectomy surgery.

NCT ID: NCT05678023 Recruiting - Clinical trials for Small Bowel Obstruction

Study About Contrast Media

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 2 or after 24 hours of nasogastric- tube decompression.

NCT ID: NCT05686317 Recruiting - Heart Failure Clinical Trials

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

ALT-FLOW II
Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, randomized, sham-controlled clinical trial.

NCT ID: NCT05695885 Recruiting - Clinical trials for Autism Spectrum Disorder

STEPS Implementation Trial

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This study will inform understanding of how to support emerging adults with autism spectrum disorder (ASD). The investigators will use a theoretically informed and research-based transition support program developed for people with ASD and test how effective it is when delivered by community agencies. Results will provide information on the effectiveness of the program as well as on mechanisms of change and contextual factors that promote or impede implementation.